000			02242 a2200589 4500
005			20250517051737.0
264		0	_c20161107
008			201611s 0 0 eng d
022			_a1366-5928
024	7		_a10.3109/00498254.2015.1081993 _2doi
040			_aNLM _beng _cNLM
100	1		_aReese, Melinda J
245	0	0	_aDrug interaction profile of the HIV integrase inhibitor cabotegravir: assessment from in vitro studies and a clinical investigation with midazolam. _h[electronic resource]
260			_bXenobiotica; the fate of foreign compounds in biological systems _c2016
300			_a445-56 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aATP-Binding Cassette Transporters _xmetabolism
650	0	4	_aAdministration, Oral
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAnimals
650	0	4	_aAnti-HIV Agents _xadministration & dosage
650	0	4	_aArea Under Curve
650	0	4	_aCytochrome P-450 CYP3A _xchemistry
650	0	4	_aDogs
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Interactions
650	0	4	_aFemale
650	0	4	_aHIV Infections _xdrug therapy
650	0	4	_aHIV Integrase Inhibitors _xchemistry
650	0	4	_aHepatocytes _xdrug effects
650	0	4	_aHumans
650	0	4	_aInhibitory Concentration 50
650	0	4	_aMadin Darby Canine Kidney Cells
650	0	4	_aMale
650	0	4	_aMidazolam _xadministration & dosage
650	0	4	_aMiddle Aged
650	0	4	_aOrganic Anion Transport Protein 1 _xantagonists & inhibitors
650	0	4	_aOrganic Anion Transporters _xmetabolism
650	0	4	_aOrganic Anion Transporters, Sodium-Independent _xantagonists & inhibitors
650	0	4	_aPyridones _xadministration & dosage
650	0	4	_aYoung Adult
700	1		_aBowers, Gary D
700	1		_aHumphreys, Joan E
700	1		_aGould, Elizabeth P
700	1		_aFord, Susan L
700	1		_aWebster, Lindsey O
700	1		_aPolli, Joseph W
773	0		_tXenobiotica; the fate of foreign compounds in biological systems _gvol. 46 _gno. 5 _gp. 445-56
856	4	0	_uhttps://doi.org/10.3109/00498254.2015.1081993 _zAvailable from publisher's website
999			_c25232597 _d25232597